Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials 17
Clinical Trials by Phase 18
Clinical Trials by Trial Status 19
Clinical Trials by End Point Status 20
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Ichthyosis Vulgaris Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profile Snapshots 26
Appendix 34
Abbreviations 34
Definitions 34
Research Methodology 35
Secondary Research 35
About GlobalData 36
Contact Us 36
Source 36

List of Tables
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region, 2017* 6
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
Ichthyosis Vulgaris Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 14
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 17
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase, 2017* 18
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 22
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25

List of Figures
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
Ichthyosis Vulgaris Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
Ichthyosis Vulgaris Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
Ichthyosis Vulgaris Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, G7 Countries (%), 2017* 14
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
Ichthyosis Vulgaris Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
Proportion of Ichthyosis Vulgaris to Genetic Disorders Clinical Trials, E7 Countries (%), 2017* 17
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Phase (%), 2017* 18
Ichthyosis Vulgaris Therapeutics, Global, Clinical Trials by Trial Status, 2017* 19
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, by End Point Status, 2017* 20
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 21
Ichthyosis Vulgaris Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 22
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 23
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 24
Ichthyosis Vulgaris Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 25
GlobalData Methodology 35

Companies Mentioned
- Aldeyra Therapeutics Inc
- Adamis Pharmaceuticals Corp
- Therapeutics Inc
- Stiris Research Inc
- Pierre Fabre Foundation
- GlaxoSmithKline Plc
- Crown Laboratories Inc